Mr Agosti joined Takeda Pharmaceuticals in 2008 and has held several global commercial and strategy leadership positions. Currently, Mr. Agosti serves as a Global Head of Business Development and is responsible for business development activities across all therapeutic areas. Before his appointment as global head of business development, Mr Agosti led the global commercial organization, which was established as part of its plans to structure operations to become more agile and customer-focused. The global commercial organization has been created to better align with the company’s business need to maximize the product value of global brands through their lifecycle and to provide commercial leadership for pipeline compounds across the gastroenterology, cardiovascular and metabolic, and central nervous system (CNS) therapeutic areas.
Prior to joining Takeda Pharmaceuticals, Mr. Agosti served as a Head of Business Development and Licensing at Novartis and leadership positions at Capitalone.
Mr. Agosti received a Program of International Management from HEC, Paris and MBA from Oxford University.